2 completed, 1 recruiting. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Recruiting 1 |
Follow ECG test: new trials by email Literature Review of ECG test trials Research Report on ECG test
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Psychological Effects of Psilocybin and D-Serine Formulation in Healthy Volunteers Psilocybin and D-Serine, Physical Examination, Vital signs - Healthy Volunteers | Phase 1 | Recruiting | Hadassah Medical Organization | 10 | 2025-12-11 | 2026-02-05 |
| Assessment of KM-001 - Safety, Tolerability, and Efficacy in Patients With PPPK1 or PC KM-001 cream 1% 12 weeks treatment., Physical Examination, Vital Signs - Punctate Palmoplantar Keratoderma Type 1, Pachyonychia Congenita | Phase 1 | Completed | Orvida Pharma (formerly Kamari Pharma) | 18 | 2023-03-06 | 2025-01-15 |
| Study Designed to Evaluate Safety and Efficacy of 1% Topical Formulation of KM-001 on Type 1 Punctate Palmoplantar Keratoderma or Pachyonychia Congenita Diseases Serum chemistry, Hematology, Urinalysis - Punctate Palmoplantar Keratoderma Type 1, Pachyonychia Congenita | Phase 1 | Completed | Orvida Pharma (formerly Kamari Pharma) | 14 | 2022-07-17 | 2025-01-07 |
Keratosis palmoplantaris papulosa (2) · Pachyonychia Congenita (2)
Orvida Pharma (formerly Kamari Pharma) (2) · Hadassah Medical Organization (1)
Israel (2) · United Kingdom (1)